Skip to main content
Moderna, Inc. logo

Moderna, Inc. — Investor Relations & Filings

Ticker · MRNA ISIN · US60770K1079 LEI · 549300EI6OKH5K5Q2G38 US Manufacturing
Open in API
Filings indexed 1,448 across all filing types
Latest filing 2020-11-16 Director's Dealing
Country US United States of America
Listing US MRNA

About Moderna, Inc.

https://www.modernatx.com/

Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2020-11-16 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes announcements about Moderna's COVID-19 vaccine candidate meeting efficacy criteria and improvements in shelf life and storage conditions. It references press releases as exhibits and explicitly states that the information is furnished and not filed for certain regulatory purposes. The document does not contain detailed financial statements or comprehensive financial analysis, nor is it an earnings release or annual report. It is primarily an announcement of significant company developments and disclosures. Given the nature of Form 8-K filings and the content focusing on announcements rather than detailed reports, the best fitting category is Regulatory Filings (RNS). The document length is under 5,000 characters and it is a current report announcing material events, consistent with RNS classification rather than a full report type.
2020-11-16 English
4 Filing
Director's Dealing
2020-11-16 English
4 Filing
Director's Dealing
2020-11-12 English
4 Filing
Director's Dealing
2020-11-10 English
4 Filing
Director's Dealing
2020-11-10 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.